32965687
2020 Sep 23.</span
In their recent report, Goh et al. divided hepatitis B virus (HBV) infected patients into statin users (â‰¥28 cDDD [cumulative defined daily dose]) and non-users. They concluded that statins users have a lower risk of developing hepatocellular carcinoma (HCC) than statin non-users.(1) However, several limitations may temper its conclusions.

